Company / Cash per Share
Tempest Therapeutics, Inc. Cash per Share History
FY2015-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$0.44
FY2017
5-year range
$0.23 / $0.75
FY2015-FY2017
Trend
+87.5%
vs FY2016
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $0.75 to $0.44 over the past 2 years.
Based on SEC 10-K filings.
0.44 in FY2017.
Declined from $0.75 to $0.44 over the past 2 years.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2017, cash per share increased 87.5% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.69 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2017 | $0.44 | +87.5% |
| FY2016 | $0.23 | -68.7% |
| FY2015 | $0.75 | - |
As of FY2017 · SEC 10-K · Updated Jun 28, 2026